Regeneron Pharmaceuticals (REGN US)

129

Analysis

Health Care • United States

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

Refresh

Company Presentation • 12 Jun 2026 22:30

AGM 2026

Company Presentation • 09 Jan 2024 06:15

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 30 Jan 2026 21:30

Q4 2025

Company Presentation • 13 Jan 2026 01:12

44th Annual J.P. Morgan Healthcare Conference

Company Presentation • 14 Jan 2025 06:15

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AGM 2026

J.P. Morgan 42nd Annual Healthcare Conference 2024

Q4 2025

44th Annual J.P. Morgan Healthcare Conference

43rd Annual J.P. Morgan Healthcare Conference 2025